Tzu Cancer Therapeutics
Helping develop methods for single-cell multiomics analysis of CTCs.
Molecular biologist · Amsterdam
Single-cell multiomics of circulating tumor cells.
I help develop methods to extract more molecular information from a single cell.
Research at Tzu
Tzu Cancer Therapeutics combines access to rare circulating tumor cells with deep molecular profiling to explore new ways to tackle metastatic cancer.
TzuFetch enables CTC enrichment from large-volume blood sampling. The TzuPlus workflow brings cell isolation, single-cell multiomics and data analysis together, connecting DNA, RNA and protein information to investigate potential therapeutic targets.
I’m happy to be contributing to this work every day as part of the Tzu multi-omics R&D team.
Explore Tzu’s technologyBackground
My experience spans a broad range of molecular and cell biology techniques, including mammalian cell culture, CRISPR/Cas9 engineering and stem-cell-derived organoid culture, alongside PCR assay development in an ISO 13485 environment.
I’m now applying that foundation to single-cell cancer research at Tzu while completing my MSc at HAN.
MSc in Applied Molecular Sciences
HAN University of Applied Sciences · Expected 2028
MSc Healthy Society
Fontys University of Applied Sciences · 2026
BSc Biology & Medical Laboratory Research
Avans University of Applied Sciences · 2023
Helping develop methods for single-cell multiomics analysis of CTCs.
Supported PCR assay development, performance testing and quality documentation in an ISO 13485 environment.
Worked on human intestinal organoids and a Parkinson’s disease model, using stem-cell culture, CRISPR/Cas9 and molecular validation methods.
Connect
I’m interested in exchanging ideas on CTCs, single-cell multiomics and molecular approaches to cancer research. If your work overlaps with mine, feel free to get in touch.